RedHill Biopharma Schedules May 5th Shareholder Meeting
Ticker: RDHL · Form: 6-K · Filed: Apr 1, 2025 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, proxy-statement, corporate-governance
Related Tickers: RHBP
TL;DR
RHBP set May 5th for shareholder meeting, proxy docs filed.
AI Summary
RedHill Biopharma Ltd. filed a Form 6-K on April 1, 2025, to report its notice and proxy statement for the annual general meeting of shareholders scheduled for May 5, 2025. This filing is incorporated by reference into the company's existing S-8 registration statements.
Why It Matters
This filing signals upcoming corporate governance activities and potential shareholder decisions that could impact the company's strategic direction.
Risk Assessment
Risk Level: low — The filing is routine administrative information regarding a shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- RedHill Biopharma Ltd. (company) — Registrant
- May 5, 2025 (date) — Annual general meeting date
- April 1, 2025 (date) — Filing date
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K is to report the notice and proxy statement for RedHill Biopharma Ltd.'s annual general meeting of shareholders.
When is the annual general meeting of shareholders scheduled to take place?
The annual general meeting of shareholders is scheduled for May 5, 2025.
What is the company's principal executive office address?
The company's principal executive offices are located at 21 Ha'arba'a Street, Tel Aviv, 6473921, Israel.
Does RedHill Biopharma file annual reports under Form 20-F or 40-F?
RedHill Biopharma indicates it files annual reports under Form 20-F.
Which registration statements does this Form 6-K filing incorporate by reference?
This Form 6-K is incorporated by reference into the Company's Registration Statements on Form S-8 filed on May 2, 2013 (Registration No. 333-188286) and October 29, 2015 (Registration No. 333-207654).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 1, 2025 regarding RedHill Biopharma Ltd. (RDHL).